Stock listing

OTC:INBP Integrated BioPharma, Inc. Stock

Follow Integrated BioPharma, Inc. into a list and get an email when it puts out news.

Share price · OTC:INBP

$0.16 USD +0.01 (+3.2%)

Close on Nov 18, 2026

Past year -46.7% · daily closes, Nov 18, 2025 – Nov 18, 2026, adjusted for splits
Day range
$0.16 – $0.16 USDNov 18, 2026
Volume
300 sharesNov 18, 2026
Market cap
$4.97M USDAt the close on Nov 18, 2026 · price × 31.06M shares outstanding
52-week range
$0.14 – $0.42 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
Traded on an average day
$1,680 USDMedian day 900 shares · 18 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026
Integrated BioPharma, Inc. logo

Daily closes

Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:INBP · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.16+0.005+3.2%$0.16$0.16$0.16300
$0.155-0.019-10.8%$0.15$0.155$0.1511,600
$0.174+0.004+2.2%$0.174$0.174$0.174900
$0.170.000.0%$0.17$0.17$0.170
$0.170.000.0%$0.17$0.17$0.170
$0.170.000.0%$0.17$0.17$0.1716,500
$0.170.000.0%$0.17$0.17$0.170
$0.17-0.01-5.6%$0.17$0.17$0.172,700
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.1814,700
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.18600
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.18100
$0.18-0.01-5.3%$0.18$0.18$0.1814,500
$0.190.000.0%$0.18$0.19$0.185,100
$0.19+0.001+0.5%$0.19$0.19$0.191,800
$0.189-0.001-0.5%$0.198$0.198$0.18600
$0.19+0.02+11.8%$0.18$0.20$0.1882,800
$0.17-0.01-5.6%$0.17$0.17$0.1752,400
$0.180.000.0%$0.18$0.18$0.180
$0.18+0.02+12.5%$0.17$0.19$0.178,900
$0.16-0.01-5.9%$0.16$0.16$0.165,000
$0.170.000.0%$0.17$0.18$0.1745,500
$0.17-0.01-5.6%$0.18$0.18$0.17111,400
$0.18-0.01-5.3%$0.19$0.19$0.189,700
$0.190.000.0%$0.19$0.19$0.190
$0.19+0.01+5.6%$0.19$0.19$0.195,600
$0.180.000.0%$0.19$0.19$0.183,600
$0.18+0.02+12.5%$0.19$0.19$0.1847,600
$0.16-0.015-8.5%$0.17$0.17$0.16500
$0.175+0.005+2.9%$0.18$0.18$0.1752,500
$0.17-0.01-5.6%$0.18$0.18$0.164,000
$0.18+0.01+5.9%$0.18$0.18$0.181,200
$0.170.000.0%$0.17$0.17$0.170
$0.17-0.01-5.6%$0.18$0.18$0.1715,300
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.181,000
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.18-0.01-5.3%$0.18$0.18$0.1810,000
$0.19+0.01+5.6%$0.19$0.19$0.197,100
$0.18-0.01-5.3%$0.18$0.18$0.18700
$0.19+0.01+5.6%$0.18$0.19$0.18900
$0.18+0.006+3.4%$0.18$0.18$0.186,800
$0.174+0.007+4.2%$0.173$0.174$0.173600
$0.167-0.013-7.2%$0.19$0.19$0.16738,038
$0.180.000.0%$0.18$0.18$0.185,000
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.18200
$0.18+0.02+12.5%$0.18$0.18$0.18100
Ticker
OTC:INBP
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Integrated BioPharma, Inc. news

Integrated BioPharma, Inc. on 6ix

News releases
1 in the last 12 months · 1 in all · newest Nov 13, 2026 · oldest 2026
Decks
1 deck · latest Jun 13, 2005

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 18, 2026

Enterprise value
$1.85M USD
P/E
Loss
EV/sales
0.1×
EV/EBITDA
Negative EBITDA
Price/book
0.3×
Gross margin
−0.8%
Operating margin
−9.3%
Net margin
−8.9%
Debt to equity
0.0×
Beta vs S&P 500
0.02

Team and board

Officers

OfficerRole
Christina KayCo-Chief Executive Officer and Director
Riva SheppardCo-Chief Executive Officer and Director

Board

DirectorRole
Christina KayCo-Chief Executive Officer and Director
Damon DeSantisDirector
Eric FriedmanDirector
Riva SheppardCo-Chief Executive Officer and Director
Robert CanarickDirector
William H. MilmoeDirector

Events

QuarterResultsShare move
Q1 2026Nov 10, 2025−6.5%
Q4 2025Sep 23, 2025+14.3%
Q3 2025May 14, 2025+26.9%
Q2 2025Feb 7, 2025−10.3%
Q1 2025Nov 14, 2024+6.3%
Q4 2024Sep 20, 2024+8.7%
Q3 2024May 10, 20240.0%
Q2 2024Feb 12, 2024−13.0%
Q1 2024Nov 9, 2023 · Before open0.0%
Q4 2023Sep 15, 2023 · After close0.0%
All 20 quarters
QuarterResultsShare move
Q3 2023May 11, 2023 · Before open−5.9%
Q2 2023Feb 10, 2023 · After close+5.4%
Q1 2023Nov 10, 2022+4.9%
Q4 2022Sep 13, 2022−12.1%
Q3 2022May 12, 2022+11.1%
Q2 2022Feb 10, 2022−3.0%
Quarter to Sep 30, 2021Nov 10, 2021−10.5%
Quarter to Jun 30, 2021Sep 2, 2021+21.1%
Quarter to Mar 31, 2021May 13, 2021+19.4%
Quarter to Dec 31, 2020Feb 12, 2021+13.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (June 2005)Investor deck12 slidesJun 13, 2005

Open Decks

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018
Revenue43.9M54.4M50.3M50.7M56.2M63.6M52.8M50.0M43.7M31.1M
Cost of revenue43.1M48.8M46.4M46.6M49.7M54.1M46.0M43.8M38.7M27.6M
Gross profit800.0K5.56M3.88M4.06M6.55M9.48M6.73M6.22M4.99M3.52M
Selling, general and administrative3.50M3.54M3.63M3.94M3.81M3.70M3.47M3.52M3.29M2.45M
Operating income-2.71M2.02M251.0K120.0K2.75M5.78M3.26M2.70M1.69M1.07M
Depreciation and amortization293.0K318.0K307.0K351.0K336.0K337.0K312.0K321.0K348.0K
EBITDA-2.41M2.34M558.0K471.0K3.08M6.12M3.57M3.02M2.04M
Interest expense12.0K46.0K52.0K52.0K128.0K256.0K397.0K630.0K926.0K694.0K
Income before tax-2.56M2.06M268.0K100.0K2.60M7.25M3.09M2.04M1.00M258.0K
Income tax279.0K1.25M156.0K134.0K-1.24M-766.0K-1.02M354.0K326.0K397.0K
Net income-2.84M808.0K112.0K-34.0K3.84M8.01M4.11M1.69M679.0K-139.0K
Earnings per share, basic-0.090.030.000.000.130.270.140.060.03-0.01
Earnings per share, diluted-0.090.030.000.000.120.250.130.060.02-0.01

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018
Cash and equivalents4.47M3.62M1.68M1.32M331.0K210.0K402.0K475.0K228.0K62.0K
Receivables3.33M5.43M4.67M4.51M4.89M5.78M5.51M4.44M3.80M3.20M
Inventory9.14M9.36M11.2M10.3M11.1M11.7M11.7M8.82M7.74M8.55M
Current assets17.4M18.8M17.9M16.4M16.6M18.0M16.5M14.1M12.3M12.3M
Property, plant and equipment1.75M1.72M1.80M1.65M1.91M1.74M1.74M1.78M1.78M1.67M
Total assets25.3M24.9M26.2M26.2M25.3M25.4M22.9M19.8M14.6M14.6M
Accounts payable3.20M2.27M2.51M2.27M3.21M3.50M4.36M3.85M4.18M4.88M
Current liabilities5.80M4.25M6.12M4.83M5.26M9.24M13.1M12.4M16.2M11.3M
Long-term debt7.00K53.0K01.44M2.72M3.62M3.73M
Total debt0101.0K3.64M8.34M9.65M9.34M8.95M
Total liabilities7.67M4.58M6.97M6.57M6.67M11.1M16.9M17.9M19.8M20.7M
Shareholders' equity17.7M20.3M19.2M18.9M18.6M14.3M6.07M1.89M-5.24M-6.06M
Shares outstanding31.1M31.1M30.1M29.9M29.9M29.8M29.6M29.6M21.1M21.2M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations1.24M2.06M943.0K1.23M4.09M3.05M1.34M328.0K1.17M
Capital spending-346.0K-191.0K-553.0K-116.0K-486.0K-295.0K-214.0K-414.0K-247.0K
Free cash flow895.0K1.87M390.0K1.12M3.60M2.75M1.13M-86.0K921.0K
Cash from investing-340.0K-205.0K-553.0K-111.0K-465.0K-199.0K-110.0K-422.0K-242.0K
Cash from financing-45.0K78.0K-29.0K-136.0K-3.50M-3.04M-1.30M341.0K-830.0K
Change in cash856.0K1.94M361.0K985.0K121.0K-192.0K-73.0K247.0K96.0K

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 13, 2026ResultsSEC
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
DEF 14A · Proxy statementOct 28, 2026Meeting noticeSEC
8-K · Current reportSep 25, 2026ResultsSEC
10-K · Annual reportSep 25, 2026Annual reportSEC
8-K · Current reportAug 20, 2026Current reportSEC
8-K · Current reportJul 2, 2026Material contractSEC
4/A · Change in ownership, amendedJun 25, 2026Insider tradeSEC
4 · Change in ownershipJun 25, 2026Insider tradeSEC
4 · Change in ownershipJun 25, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJun 25, 2026Insider tradeSEC
4 · Change in ownershipJun 25, 2026Insider tradeSEC
8-K · Current reportMay 8, 2026ResultsSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 17, 2026Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeApr 17, 2026Big-stake noticeSEC
4/A · Change in ownership, amendedApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
8-K · Current reportApr 15, 2026Current reportSEC
4 · Change in ownershipMar 26, 2026Insider tradeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
8-K · Current reportFeb 18, 2026Material contractSEC
8-K · Current reportFeb 11, 2026ResultsSEC
10-Q · Quarterly reportFeb 11, 2026Quarterly reportSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
8-K · Current reportDec 1, 2025Meeting outcomeSEC
8-K · Current reportNov 10, 2025ResultsSEC
10-Q · Quarterly reportNov 10, 2025Quarterly reportSEC
DEF 14A · Proxy statementOct 28, 2025Meeting noticeSEC
8-K · Current reportSep 23, 2025ResultsSEC
10-K · Annual reportSep 23, 2025Annual reportSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
8-K · Current reportMay 14, 2025ResultsSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportApr 24, 2025Current reportSEC
8-K · Current reportApr 21, 2025Material contractSEC
8-K · Current reportFeb 13, 2025ResultsSEC
10-Q · Quarterly reportFeb 13, 2025Quarterly reportSEC
4 · Change in ownershipDec 5, 2024Insider tradeSEC
4 · Change in ownershipDec 5, 2024Insider tradeSEC
4 · Change in ownershipDec 5, 2024Insider tradeSEC
8-K · Current reportDec 2, 2024Meeting outcomeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
8-K · Current reportNov 14, 2024ResultsSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
DEF 14A · Proxy statementOct 28, 2024Meeting noticeSEC
8-K · Current reportSep 23, 2024ResultsSEC
10-K · Annual reportSep 20, 2024Annual reportSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
8-K · Current reportMay 10, 2024ResultsSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
8-K · Current reportFeb 12, 2024ResultsSEC
10-Q · Quarterly reportFeb 12, 2024Quarterly reportSEC
4 · Change in ownershipNov 29, 2023Insider tradeSEC
4 · Change in ownershipNov 29, 2023Insider tradeSEC
4 · Change in ownershipNov 29, 2023Insider tradeSEC
8-K · Current reportNov 27, 2023Meeting outcomeSEC
SC 13D · Big-stake noticeNov 16, 2023Big-stake noticeSEC
5 · Annual statement of ownershipNov 16, 2023Insider tradeSEC
3 · Initial statement of ownershipNov 16, 2023Insider tradeSEC
SC 13D · Big-stake noticeNov 14, 2023Big-stake noticeSEC
8-K · Current reportNov 9, 2023ResultsSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
DEF 14A · Proxy statementOct 27, 2023Meeting noticeSEC
4 · Change in ownershipSep 21, 2023Insider tradeSEC
4 · Change in ownershipSep 21, 2023Insider tradeSEC
4 · Change in ownershipSep 21, 2023Insider tradeSEC
8-K · Current reportSep 15, 2023ResultsSEC
10-K · Annual reportSep 15, 2023Annual reportSEC
4 · Change in ownershipJul 20, 2023Insider tradeSEC
4 · Change in ownershipJul 19, 2023Insider tradeSEC
4 · Change in ownershipJul 19, 2023Insider tradeSEC
4 · Change in ownershipJul 19, 2023Insider tradeSEC
4 · Change in ownershipJun 1, 2023Insider tradeSEC
4 · Change in ownershipJun 1, 2023Insider tradeSEC
8-K · Current reportMay 11, 2023ResultsSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportMar 21, 2023Current reportSEC
8-K · Current reportMar 17, 2023Material contractSEC
8-K · Current reportFeb 10, 2023ResultsSEC
10-Q · Quarterly reportFeb 10, 2023Quarterly reportSEC
8-K · Current reportDec 6, 2022Material contractSEC
8-K · Current reportNov 28, 2022Meeting outcomeSEC
8-K/A · Current report, amendedNov 14, 2022ResultsSEC
8-K · Current reportNov 14, 2022ResultsSEC
4 · Change in ownershipNov 10, 2022Insider tradeSEC
4 · Change in ownershipNov 10, 2022Insider tradeSEC
4 · Change in ownershipNov 10, 2022Insider tradeSEC
4 · Change in ownershipNov 10, 2022Insider tradeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
DEF 14A · Proxy statementOct 27, 2022Meeting noticeSEC
8-K · Current reportOct 24, 2022Current reportSEC
8-K · Current reportSep 14, 2022ResultsSEC
10-K · Annual reportSep 13, 2022Annual reportSEC
8-K · Current reportJul 15, 2022Material contractSEC
4 · Change in ownershipJun 21, 2022Insider tradeSEC
3 · Initial statement of ownershipJun 21, 2022Insider tradeSEC
8-K · Current reportJun 21, 2022Management or board changeSEC
4 · Change in ownershipJun 21, 2022Insider tradeSEC
4 · Change in ownershipJun 21, 2022Insider tradeSEC
4 · Change in ownershipJun 21, 2022Insider tradeSEC
8-K · Current reportMay 12, 2022ResultsSEC
10-Q · Quarterly reportMay 12, 2022Quarterly reportSEC
4/A · Change in ownership, amendedMay 11, 2022Insider tradeSEC
4 · Change in ownershipMay 6, 2022Insider tradeSEC
8-K · Current reportFeb 10, 2022ResultsSEC
10-Q · Quarterly reportFeb 10, 2022Quarterly reportSEC
8-K · Current reportNov 29, 2021Meeting outcomeSEC
8-K · Current reportNov 10, 2021ResultsSEC
10-Q · Quarterly reportNov 10, 2021Quarterly reportSEC
4 · Change in ownershipNov 4, 2021Insider tradeSEC
4 · Change in ownershipNov 4, 2021Insider tradeSEC
4 · Change in ownershipNov 4, 2021Insider tradeSEC
4 · Change in ownershipNov 3, 2021Insider tradeSEC
4 · Change in ownershipNov 3, 2021Insider tradeSEC
4 · Change in ownershipNov 3, 2021Insider tradeSEC
4 · Change in ownershipNov 3, 2021Insider tradeSEC
4 · Change in ownershipNov 3, 2021Insider tradeSEC
DEF 14A · Proxy statementOct 27, 2021Meeting noticeSEC
8-K · Current reportSep 2, 2021ResultsSEC
10-K · Annual reportSep 2, 2021Annual reportSEC
8-K · Current reportJul 7, 2021Current reportSEC
8-K · Current reportMay 13, 2021ResultsSEC
10-Q · Quarterly reportMay 13, 2021Quarterly reportSEC
8-K · Current reportApr 8, 2021Current reportSEC
8-K · Current reportFeb 12, 2021ResultsSEC
10-Q · Quarterly reportFeb 12, 2021Quarterly reportSEC
8-K · Current reportJan 22, 2021Current reportSEC
8-K · Current reportNov 30, 2020Meeting outcomeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
3 · Initial statement of ownershipNov 17, 2020Insider tradeSEC
8-K · Current reportNov 12, 2020ResultsSEC
10-Q · Quarterly reportNov 12, 2020Quarterly reportSEC
8-K · Current reportNov 9, 2020Management or board changeSEC
DEF 14A · Proxy statementOct 28, 2020Meeting noticeSEC
8-K · Current reportSep 24, 2020Current reportSEC
10-K · Annual reportSep 23, 2020Annual reportSEC
8-K · Current reportMay 13, 2020ResultsSEC
10-Q · Quarterly reportMay 13, 2020Quarterly reportSEC
8-K · Current reportFeb 12, 2020ResultsSEC
10-Q · Quarterly reportFeb 12, 2020Quarterly reportSEC
8-K · Current reportDec 3, 2019Meeting outcomeSEC
8-K · Current reportNov 13, 2019ResultsSEC
10-Q · Quarterly reportNov 13, 2019Quarterly reportSEC
DEF 14A · Proxy statementOct 28, 2019Meeting noticeSEC
8-K · Current reportSep 16, 2019FinancingSEC
10-K · Annual reportAug 29, 2019Annual reportSEC
4 · Change in ownershipMay 29, 2019Insider tradeSEC
4 · Change in ownershipMay 29, 2019Insider tradeSEC
4 · Change in ownershipMay 29, 2019Insider tradeSEC
4 · Change in ownershipMay 29, 2019Insider tradeSEC
4 · Change in ownershipMay 29, 2019Insider tradeSEC
4 · Change in ownershipMay 29, 2019Insider tradeSEC
4 · Change in ownershipMay 29, 2019Insider tradeSEC
8-K · Current reportMay 29, 2019Management or board changeSEC
8-K · Current reportMay 15, 2019ResultsSEC
10-Q · Quarterly reportMay 15, 2019Quarterly reportSEC
8-K · Current reportMay 6, 2019Management or board changeSEC
10-Q · Quarterly reportFeb 13, 2019Quarterly reportSEC
S-8 · Registration statement for employee plansDec 28, 2018Offer documentSEC
4/A · Change in ownership, amendedDec 19, 2018Insider tradeSEC
4/A · Change in ownership, amendedDec 19, 2018Insider tradeSEC
4 · Change in ownershipDec 19, 2018Insider tradeSEC
4 · Change in ownershipDec 19, 2018Insider tradeSEC
4 · Change in ownershipDec 19, 2018Insider tradeSEC
8-K · Current reportNov 26, 2018Meeting outcomeSEC
10-Q · Quarterly reportNov 9, 2018Quarterly reportSEC
DEF 14A · Proxy statementOct 29, 2018Meeting noticeSEC
10-K · Annual reportSep 12, 2018Annual reportSEC
4 · Change in ownershipAug 1, 2018Insider tradeSEC
4 · Change in ownershipAug 1, 2018Insider tradeSEC
4 · Change in ownershipAug 1, 2018Insider tradeSEC
8-K · Current reportAug 1, 2018FinancingSEC
10-Q · Quarterly reportMay 9, 2018Quarterly reportSEC
10-Q · Quarterly reportFeb 9, 2018Quarterly reportSEC

This page holds 200 of 559 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Integrated BioPharma, Inc.’s releases · as of Sep 23, 2026

Common shares
31,059,610
Fully diluted
31,059,610

Fully diluted

LineSharesAs of
Common shares31,059,610Sep 23, 2026

Share count over time

CountShares
Sep 23, 202631,059,610

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dina Masi
Other companies: iBio, Inc. (Interim CFO · Aug 12, 2008 – Aug 12, 2008 · Past)
Chief Financial Officer · Since at least Jun 30, 2008
Christina KayCo-Chief Executive Officer, Director · Since at least May 21, 2025
Damon DeSantisDirector · Since at least Nov 5, 2026
E Gerald KayExecutive Chairman & President, Director · May 6, 2022 – Jun 30, 2023 · Past
Eric FriedmanDirector · Since at least Nov 5, 2026
Riva SheppardCo-Chief Executive Officer and Director · Since at least Nov 5, 2026
Robert CanarickDirector · Since at least Nov 5, 2026
Sheppard RivaCo-Chief Executive Officer · Since at least Nov 4, 2020
William H. MilmoeDirector · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Integrated BioPharma, Inc.